Gemcell plus xeno freelot H423031

Ended Purchase Order Awarded Last action

Contract number
75N90024P00630
Awardee
Awarding agency
Obligated
$61,728

Award facts

Contract value 100% obligated
$61,728.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Broderick, CA 95605, USA

Award details come from SAM.gov/FPDS.

About this award

This $61,728 firm fixed price purchase order was awarded on September 11, 2024 to Gemini Bioproducts LLC, a for-profit manufacturer of cell culture media, sera, and other reagents. The contract supports the National Institutes of Health (NIH) Clinical Center with the supply of GemCell Plus Xeno-Free Lot H423031 products. Gemini Bioproducts has received prior sole source awards from NIH and the U.S. Department of Agriculture to provide specialized cell culture and viral transport media products. This award is not set aside and is part of a larger $200 million indefinite delivery, indefinite quantity (IDIQ) contract that Gemini holds with the Federal Emergency Management Agency (FEMA) to rapidly procure COVID-19 response supplies.

Quick answers

Who was awarded contract 75N90024P00630?

75N90024P00630 was awarded to Gemini Bioproducts LLC by NIH Clinical Center (National Institutes of Health) on September 11, 2024.

How much is contract 75N90024P00630 worth?

The government has obligated $61,728 on 75N90024P00630.

Was contract 75N90024P00630 competed?

The extent of competition for 75N90024P00630 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award